Letter to the Editor of Public Health in response to Lim et al., Influenza A(H1N1)pdm09 infection in pregnant and non-pregnant women

Public Health ◽  
2016 ◽  
Vol 139 ◽  
pp. 238
Author(s):  
V. Wiwanitkit
Eye ◽  
2021 ◽  
Author(s):  
Ashwin Venkatesh ◽  
Ravi Patel ◽  
Simran Goyal ◽  
Timothy Rajaratnam ◽  
Anant Sharma ◽  
...  

AbstractEmerging infectious diseases (EIDs) are an increasing threat to public health on a global scale. In recent times, the most prominent outbreaks have constituted RNA viruses, spreading via droplets (COVID-19 and Influenza A H1N1), directly between humans (Ebola and Marburg), via arthropod vectors (Dengue, Zika, West Nile, Chikungunya, Crimean Congo) and zoonotically (Lassa fever, Nipah, Rift Valley fever, Hantaviruses). However, specific approved antiviral therapies and vaccine availability are scarce, and public health measures remain critical. Patients can present with a spectrum of ocular manifestations. Emerging infectious diseases should therefore be considered in the differential diagnosis of ocular inflammatory conditions in patients inhabiting or returning from endemic territories, and more general vigilance is advisable in the context of a global pandemic. Eye specialists are in a position to facilitate swift diagnosis, improve clinical outcomes, and contribute to wider public health efforts during outbreaks. This article reviews those emerging viral diseases associated with reports of ocular manifestations and summarizes details pertinent to practicing eye specialists.


2011 ◽  
Vol 204 (6) ◽  
pp. S21-S30 ◽  
Author(s):  
Sascha R. Ellington ◽  
Laura K. Hartman ◽  
Meileen Acosta ◽  
Miguel Martinez-Romo ◽  
Lewis Rubinson ◽  
...  

Vaccine ◽  
2012 ◽  
Vol 30 (52) ◽  
pp. 7630-7636 ◽  
Author(s):  
Wakaba Fukushima ◽  
Satoko Ohfuji ◽  
Masaaki Deguchi ◽  
Kazume Kawabata ◽  
Hideaki Hatayama ◽  
...  

PLoS ONE ◽  
2009 ◽  
Vol 4 (12) ◽  
pp. e8356 ◽  
Author(s):  
Matthias an der Heiden ◽  
Udo Buchholz ◽  
Gérard Krause ◽  
Göran Kirchner ◽  
Hermann Claus ◽  
...  

2010 ◽  
Vol 14 ◽  
pp. e96
Author(s):  
A. Ribeiro ◽  
G.D. Freitas ◽  
A.C.G. Pellini ◽  
T.R.M.P. Carvalhanas ◽  
A.L.F. Yu ◽  
...  

2011 ◽  
Vol 140 (7) ◽  
pp. 1316-1327 ◽  
Author(s):  
E. ROLLAND-HARRIS ◽  
J. VACHON ◽  
R. KROPP ◽  
J. FROOD ◽  
K. MORRIS ◽  
...  

SUMMARYThis article describes the epidemiology of pandemic A(H1N1) 2009 influenza in all Canadian pregnant women admitted to hospital, and compares it with historical inter-pandemic influenza activity. We used weekly hospitalization and death counts of laboratory-confirmed pandemic A(H1N1) influenza cases reported to the Public Health Agency of Canada's (PHAC) 2009–2010 national pandemic influenza surveillance programme. Pregnant women infected and admitted with the pandemic strain were described and compared with: (1) confirmed admissions of all women of reproductive age; (2) all admitted cases reported to PHAC; and (3) to a historical average of inter-pandemic seasonal influenza admissions, and pneumonia and influenza (P&I) admissions for pregnant women. During the pandemic, 263 pregnant women with confirmed infections were admitted; four died in their third trimester. The median age for admitted pregnant cases was 27·5 years, which is consistent with the median age of the 3-year historical inter-pandemic pregnant comparison group. Aboriginal women appeared to be overrepresented but ethnicity was unavailable for 15·2% of all pregnant cases. Overall admission volumes were higher than those for seasonal influenza in the historical comparison group but were lower than those for P&I admissions. Despite increased admission volumes, severe outcomes in pregnant women were proportionally fewer than in all cases admitted for influenza A(H1N1) infection during the pandemic.


PLoS ONE ◽  
2018 ◽  
Vol 13 (3) ◽  
pp. e0194392 ◽  
Author(s):  
Ana Freitas Ribeiro ◽  
Alessandra Cristina Guedes Pellini ◽  
Beatriz Yuko Kitagawa ◽  
Daniel Marques ◽  
Geraldine Madalosso ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document